{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:04Z","timestamp":1786119064141,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1097\/inf.0b013e318149dfea","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T18:15:20Z","timestamp":1236104120000},"page":"979-984","source":"Crossref","is-referenced-by-count":83,"title":["Human Papilloma Virus Immunization in Adolescent and Young Adults"],"prefix":"10.1097","volume":"26","author":[{"given":"Claire-Anne","family":"Siegrist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin M.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhani","family":"Eskola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J. W.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven B.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210202","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/jama.296.6.640","article-title":"CDC panel backs routine HPV vaccination.","volume":"296","author":"Kuehn","year":"2006","journal-title":"JAMA"},{"issue":"6 suppl","key":"R2-3-20210202","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jadohealth.2005.09.010","article-title":"Improving adolescent health: focus on HPV vaccine acceptance.","volume":"37","author":"Zimet","year":"2005","journal-title":"J Adolesc Health"},{"key":"R3-3-20210202","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1542\/peds.2005-1381","article-title":"Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV.","volume":"117","author":"Dempsey","year":"2006","journal-title":"Pediatrics"},{"key":"R4-3-20210202","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1158\/1055-9965.EPI-06-0041","article-title":"Mothers\u2019 attitudes towards preventing cervical cancer through human papillomavirus vaccination: a qualitative study.","volume":"15","author":"Waller","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R5-3-20210202","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ygyno.2006.02.003","article-title":"Are women ready for the HPV vaccine?","volume":"103","author":"Slomovitz","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R6-3-20210202","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"R7-3-20210202","first-page":"37","article-title":"Vaccination against hepatitis B in France in 1996.","volume":"91","author":"Denis","year":"1998","journal-title":"Bull Soc Pathol Exot"},{"key":"R8-3-20210202","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/0140-6736(91)92034-Y","article-title":"Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine.","volume":"338","author":"Herroelen","year":"1991","journal-title":"Lancet"},{"key":"R9-3-20210202","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.281.5377.630","article-title":"A shadow falls on hepatitis B vaccination effort.","volume":"281","author":"Marshall","year":"1998","journal-title":"Science"},{"key":"R10-3-20210202","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1212\/WNL.64.7.1317-a","article-title":"Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study.","volume":"64","author":"DeStefano","year":"2005","journal-title":"Neurology"},{"key":"R11-3-20210202","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mehy.2005.08.012","article-title":"Multiple sclerosis and hepatitis B vaccination: adding the credibility of molecular biology to an unusual level of clinical and epidemiological evidence.","volume":"66","author":"Comenge","year":"2006","journal-title":"Med Hypotheses"},{"key":"R12-3-20210202","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.medmal.2003.12.010","article-title":"Evolution of strategy and coverage rates for hepatitis B vaccination in France, a country with low endemicity.","volume":"34","author":"Denis","year":"2004","journal-title":"Med Mal Infect"},{"issue":"suppl 1","key":"R13-3-20210202","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/S0168-8278(03)00153-3","article-title":"Safety of immunization and adverse events following vaccination against hepatitis B.","volume":"39","author":"Duclos","year":"2003","journal-title":"J Hepatol"},{"key":"R14-3-20210202","first-page":"1023","article-title":"Guillain-Barr\u00e9 Syndrome Among Recipients of Menactra\u00ae Meningococcal Conjugate Vaccine\u2014United States, June-July 2005,","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R15-3-20210202","first-page":"1120","article-title":"Update: Guillain-Barr\u00e9 Syndrome Among Recipients of Menactra\u00ae Meningococcal Conjugate Vaccine\u2014United States, June 2005-September 2006.","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R16-3-20210202","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1345\/aph.1G723","article-title":"Human papillomavirus vaccines.","volume":"40","author":"Schmiedeskamp","year":"2006","journal-title":"Ann Pharmacother"},{"key":"R17-3-20210202","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI28607","article-title":"Prophylactic human papillomavirus vaccines.","volume":"116","author":"Lowy","year":"2006","journal-title":"J Clin Invest"},{"key":"R18-3-20210202","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","article-title":"Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis.","volume":"366","author":"Clifford","year":"2005","journal-title":"Lancet"},{"key":"R19-3-20210202","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1053\/spid.2002.125864","article-title":"The science of evaluation of adverse events associated with vaccination.","volume":"13","author":"Halsey","year":"2002","journal-title":"Semin Pediatr Infect Dis"},{"key":"R20-3-20210202","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00002018-200225030-00001","article-title":"Monitoring the safety of vaccines: assessing the risks.","volume":"25","author":"Ellenberg","year":"2002","journal-title":"Drug Saf"},{"key":"R21-3-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268806007096","article-title":"The Lyme vaccine: a cautionary tale.","volume":"135","author":"Nigrovic","year":"2007","journal-title":"Epidemiol Infect"},{"key":"R22-3-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jaut.1999.0346","article-title":"Vaccination and autoimmunity-\u201cvaccinosis\u201d: a dangerous liaison?","volume":"14","author":"Shoenfeld","year":"2000","journal-title":"J Autoimmun"},{"key":"R23-3-20210202","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(03)14802-7","article-title":"Vaccination and autoimmune disease: what is the evidence?","volume":"362","author":"Wraith","year":"2003","journal-title":"Lancet"},{"key":"R24-3-20210202","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1468-1331.2006.01342.x","article-title":"The epidemiology of multiple sclerosis in Europe.","volume":"13","author":"Pugliatti","year":"2006","journal-title":"Eur J Neurol"},{"key":"R25-3-20210202","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2893.2003.00423.x","article-title":"Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review.","volume":"10","author":"Demicheli","year":"2003","journal-title":"J Viral Hepat"},{"key":"R26-3-20210202","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1586\/14760584.1.4.461","article-title":"Hepatitis B vaccine and risk of multiple sclerosis.","volume":"1","author":"DeStefano","year":"2002","journal-title":"Expert Rev Vaccines"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-200711000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:40:59Z","timestamp":1786038059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200711000-00003"}},"subtitle":["A Cohort Study to Illustrate What Events Might be Mistaken for Adverse Reactions"],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e318149dfea","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}